Radio-Frequency Ablation Equipment as a treatment for metastatic Liver tumors: prospective observational study (RAFAEL-study)

Radio-Frequency Ablation Equipment as a treatment for metastatic Liver tumors: prospective observational study (RAFAEL-study) - Radio-Frequency Ablation Equipment as a treatment for metastatic Liver tumors: prospective observational study (RAFAEL-study)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020250

Enrollment

500

Registered

2016-01-04

Start date

2016-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic liver tumor

Interventions

Radiofrequency abltion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Liver metastsisi from solid tumors 2.No liver dysfunction 3.Inforomed consent from patient

Exclusion criteria

Exclusion criteria: 1.hematological malignant tumor or small cell malignant tumors. 2.Dysfaunction of duodenum papilla 3.Platelet counts less than 50000 or PT% less than 50. 4.Not suitable for other reasons.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Survival time from radiofrequency abltion therapy, local recurrence rate, complication rate	—

Countries

Japan

Contacts

Public ContactTakamasa Ohki

Mitsui Memorail Hospital Gastroenterology

anb72547@nifty.com03-3862-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026